Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (28)
Qianyan Li, Arshdeep Kaur, Kyoko Okada, Richard J. McKenney & JoAnne Engebrecht. (2023) Differential requirement for BRCA1-BARD1 E3 ubiquitin ligase activity in DNA damage repair and meiosis in the Caenorhabditis elegans germ line. PLOS Genetics 19:1, pages e1010457.
Crossref
Crossref
Ayse Ozmen Yaylaci & Mediha Canbek. (2022) The role of ubiquitin signaling pathway on liver regeneration in rats. Molecular and Cellular Biochemistry 478:1, pages 131-147.
Crossref
Crossref
Brittany M. Haynes, Kristen Cunningham & Malathy P. V. Shekhar. (2022) RAD6 inhibition enhances paclitaxel sensitivity of triple negative breast cancer cells by aggravating mitotic spindle damage. BMC Cancer 22:1.
Crossref
Crossref
Yu Jeong Choi, Boyeon Kim, Yoonjung Kim, Saeam Shin & Kyung-A Lee. (2022) Applying Functional Assay Evidence to Interpret Sequence Variants Identified in Hereditary Cancer Genes. Laboratory Medicine Online 12:3, pages 145-158.
Crossref
Crossref
Maria Russi, Domenico Marson, Alice Fermeglia, Suzana Aulic, Maurizio Fermeglia, Erik Laurini & Sabrina Pricl. (2022) The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer. Pharmacology & Therapeutics 232, pages 108009.
Crossref
Crossref
Reiko Yoshida. (2020) Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis. Breast Cancer 28:6, pages 1167-1180.
Crossref
Crossref
Samuel R. WitusMikaela D. StewartRachel E. Klevit. (2021) The BRCA1/BARD1 ubiquitin ligase and its substrates. Biochemical Journal 478:18, pages 3467-3483.
Crossref
Crossref
Parasvi S. Patel, Arash Algouneh & Razq Hakem. (2021) Exploiting synthetic lethality to target BRCA1/2-deficient tumors: where we stand. Oncogene 40:17, pages 3001-3014.
Crossref
Crossref
Maria Patrizia Somma, Evgeniya N. Andreyeva, Gera A. Pavlova, Claudia Pellacani, Elisabetta Bucciarelli, Julia V. Popova, Silvia Bonaccorsi, Alexey V. Pindyurin & Maurizio Gatti. (2020) Moonlighting in Mitosis: Analysis of the Mitotic Functions of Transcription and Splicing Factors. Cells 9:6, pages 1554.
Crossref
Crossref
Sofía Carbajosa, María Florencia Pansa, Natalia S. Paviolo, Andrés M. Castellaro, Diego L. Andino, Ayelén D. Nigra, Iris Alejandra García, Ana C. Racca, Lucía Rodriguez-Berdini, Virginia Angiolini, Laura Guantay, Florencia Villafañez, María Belén Federico, María Celeste Rodríguez-Baili, Beatriz L. Caputto, Gerard Drewes, Kevin P. Madauss, Israel Gloger, Elmer Fernandez, Germán A. Gil, José Luis Bocco, Vanesa Gottifredi & Gastón Soria. (2019) Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction. Clinical Cancer Research 25:13, pages 4049-4062.
Crossref
Crossref
Qianyan Li, Takamune T. Saito, Marina Martinez-Garcia, Alison J. Deshong, Saravanapriah Nadarajan, Katherine S. Lawrence, Paula M. Checchi, Monica P. Colaiacovo & JoAnne Engebrecht. (2018) The tumor suppressor BRCA1-BARD1 complex localizes to the synaptonemal complex and regulates recombination under meiotic dysfunction in Caenorhabditis elegans. PLOS Genetics 14:11, pages e1007701.
Crossref
Crossref
Sharon B. Cantor & Sumeet Nayak. (2016) FANCJ at the FORK. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 788, pages 7-11.
Crossref
Crossref
S Lüddecke, N Ertych, A Stenzinger, W Weichert, T Beissbarth, J Dyczkowski, J Gaedcke, O Valerius, G H Braus, M Kschischo & H Bastians. (2015) The putative oncogene CEP72 inhibits the mitotic function of BRCA1 and induces chromosomal instability. Oncogene 35:18, pages 2398-2406.
Crossref
Crossref
Norman ErtychAiline StolzOliver Valerius, Gerhard H. Braus & Holger Bastians. (2016)
CHK2
–
BRCA1
tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly
. Proceedings of the National Academy of Sciences 113:7, pages 1817-1822.
Crossref
Crossref
Pierre Gönczy. (2015) Centrosomes and cancer: revisiting a long-standing relationship. Nature Reviews Cancer 15:11, pages 639-652.
Crossref
Crossref
Yu Lu & Richard Roy. (2014) Centrosome/Cell Cycle Uncoupling and Elimination in the Endoreduplicating Intestinal Cells of C. elegans. PLoS ONE 9:10, pages e110958.
Crossref
Crossref
J Sternemalm, H G Russnes, X Zhao, B Risberg, S Nord, C Caldas, A L Børresen-Dale, T Stokke & S Patzke. (2014) Nuclear CSPP1 expression defined subtypes of basal-like breast cancer. British Journal of Cancer 111:2, pages 326-338.
Crossref
Crossref
Z Shang, L Yu, Y-F Lin, S Matsunaga, C-Y Shen & B P C Chen. (2014) DNA-PKcs activates the Chk2–Brca1 pathway during mitosis to ensure chromosomal stability. Oncogenesis 3:2, pages e85-e85.
Crossref
Crossref
Valenti Gomez & Alexander Hergovich. (2014) OLA1 in Centrosome Biology alongside the BRCA1/BARD1 Complex: Looking beyond Centrosomes. Molecular Cell 53:1, pages 3-5.
Crossref
Crossref
Jianqiu Zou, Fen Tian, Ji Li, Wyatt Pickner, Molly Long, Khosrow Rezvani, Hongmin Wang & Dong Zhang. (2013) FancJ regulates interstrand crosslinker induced centrosome amplification through the activation of polo-like kinase 1. Biology Open 2:10, pages 1022-1031.
Crossref
Crossref
Liyuan Zheng, Aiping Song, Yuan Ruan, Lan Chen, Dongge Liu, Xianghong Li, Hongyan Guo, Jiyuan Han, Yan Li, Xinxia Tian & Weigang Fang. (2013) Genetic polymorphisms in AURKA, BRCA1, CCNE1 and CDK2 are associated with ovarian cancer susceptibility among Chinese Han women. Cancer Epidemiology 37:5, pages 639-646.
Crossref
Crossref
Z Kais, N Chiba, C Ishioka & J D Parvin. (2011) Functional differences among BRCA1 missense mutations in the control of centrosome duplication. Oncogene 31:6, pages 799-804.
Crossref
Crossref
Zeina Kais & Jeffrey D. Parvin. 2012. The Centrosome. The Centrosome
243
253
.
Enrico Cappelli, Stuart Townsend, Carol Griffin & John Thacker. (2011) Homologous recombination proteins are associated with centrosomes and are required for mitotic stability. Experimental Cell Research 317:8, pages 1203-1213.
Crossref
Crossref
Ailine Stolz, Norman Ertych & Holger Bastians. (2011)
Tumor Suppressor
CHK2
: Regulator of DNA Damage Response and Mediator of Chromosomal Stability
. Clinical Cancer Research 17:3, pages 401-405.
Crossref
Crossref
T. Focken, D. Steinemann, B. Skawran, W. Hofmann, P. Ahrens, N. Arnold, P. Kroll, H. Kreipe, B. Schlegelberger & D. Gadzicki. (2011) Human <i>BRCA1</i>-Associated Breast Cancer: No Increase in Numerical Chromosomal Instability Compared to Sporadic Tumors. Cytogenetic and Genome Research 135:2, pages 84-92.
Crossref
Crossref
Kirsty M. Brodie & Beric R. Henderson. (2010) Differential modulation of BRCA1 and BARD1 nuclear localisation and foci assembly by DNA damage. Cellular Signalling 22:2, pages 291-302.
Crossref
Crossref
Inês Cunha-Ferreira, Inês Bento & Mónica Bettencourt-Dias. (2009) From Zero to Many: Control of Centriole Number in Development and Disease. Traffic 10:5, pages 482-498.
Crossref
Crossref